|
Mar 19
|
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
|
|
Dec 21
|
Evaxion Biotech Announces Closing of Private Placement
|
|
Dec 19
|
Evaxion Announces Business Update and Third Quarter 2023 Financial Results
|
|
Dec 19
|
Evaxion Biotech Announces Private Placement Financing
|
|
Nov 28
|
Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept
|
|
Nov 6
|
Evaxion Shares Latest EVX-01 Phase 2 Clinical Data in Webinar with Key Opinion Leader Adnan Khattak
|
|
May 25
|
Evaxion announces promising clinical Phase 1 data for its personalized cancer vaccine EVX-01
|
|
May 25
|
Evaxion unveils proprietary genetic adjuvant technology to boost the effect of DNA and mRNA vaccines
|